Publicité
Publicité

BCDA

BCDA logo

BioCardia, Inc. Common Stock

1.41
USD
Sponsorisé
+0.09
+6.82%
09 janv., 15:40 UTC -5
Fermé
exchange

Après-marché

1.43

+0.02
+1.42%

BCDA Rapports sur les bénéfices

Ratio de surprise positive

BCDA a dépassé 16 des 23 dernières estimations.

70%

Prochain rapport

Date du prochain rapport
24 mars 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.17
Variation implicite de Q3 25 (Revenue/ EPS)
--
/
-29.17%
Variation implicite de Q4 24 (Revenue/ EPS)
--
/
-32.00%

BioCardia, Inc. Common Stock earnings per share and revenue

On 12 nov. 2025, BCDA reported earnings of -0.24 USD per share (EPS) for Q3 25, missing the estimate of -0.23 USD, resulting in a -2.30% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -3.08% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analystes forecast an EPS of -0.17 USD, with revenue projected to reach -- USD, implying an baisse of -29.17% EPS, and hausse of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, BioCardia, Inc. Common Stock reported EPS of -$0.24, missing estimates by -2.3%, and revenue of $0.00, 0% as expectations.
The stock price moved down -3.08%, changed from $1.30 before the earnings release to $1.26 the day after.
The next earning report is scheduled for 24 mars 2026.
Based on 4 analystes, BioCardia, Inc. Common Stock is expected to report EPS of -$0.17 and revenue of -- for Q4 2025.
Chèque FXEmpire's Earnings Calendar for today's list of reporting companies.
Publicité